Diagnostic and Interventional Cardiology

News | Heart Failure

Abbott’s CardioMEMS HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure

February 25, 2022 – Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded ...

February 25, 2022

Jaimin Trivedi, University of Louisville Department of Cardiovascular and Thoracic Surgery

News | Heart Failure

UofL Study Shows Improvement in Heart Transplant Access, Outcomes for Black Patients

February 25, 2022 – Researchers at the University of Louisville analyzed data for heart transplants from 1987 to 2019 to ...

February 25, 2022

Intravascular Optical Coherence Tomography (IVOCT)

News | Intravascular Imaging

Dyad Medical Secures FDA Clearance For Cardiac Image Analysis Platform

February 25, 2022 – Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis called ...

February 25, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

News | Heart Failure

Breakthrough Study Uses Genetic Testing to Evaluate Risk of Heart Disease

February 25, 2022 – Dignity Health in Arizona is launching the first research study in North America in which genetic ...

February 25, 2022

The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.

News | Heart Failure

FDA Approves Empagliflozin for Reducing Risk of Heart Failure

February 24, 2022 — The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of ...

February 24, 2022

The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil lawsuit today to stop UnitedHealth Group Incorporated (United) from acquiring Change Healthcare Inc. (Change).

News | Cardiovascular Business

Justice Department Sues to Block UnitedHealth Group’s Acquisition of Change Healthcare

February 24, 2022 — The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil ...

February 24, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

We are at the precipice of a huge development in patient care, with the first smart hospital already announced last year in Southeast Asia. To keep pace, governments in the US and Europe need to increase investment in 5G networks, as these will be essential to meet the high network demands.

News | Information Technology

Significant Expansion of 5G Networks Could be the Catalyst Towards Smart Hospitals

February 24, 2022 — Imagine that you are admitted to hospital. A smart scheduling system ensures you have a bed; you ...

February 24, 2022

Scientists have already discovered that the gut microbiome is altered in people with chronic heart disease. They subsequently identified compounds that are produced by the diseased microbiome, for instance a bacterial compound called trimethylamine (TMA) that after modification in the liver of the human host causes arteriosclerosis.

News | Heart Failure

Scientists Characterize the Imbalanced Gut Bacteria of Patients with Myocardial Infarction, Angina and Heart Failure

February 21, 2022 – The human gut contains trillions of bacteria, collectively called the gut microbiome, which may have ...

February 21, 2022

Researchers at Gladstone; Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-threatening problems with the structure and function of their hearts. For most children, the precise causes of these frightening defects are unknown.

News | Congenital Heart

Getting to the Heart of Complex Disease

February 21, 2022—Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life ...

February 21, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Angioscopic findings in the FPA and infrapopliteal lesions

News | Peripheral Artery Disease (PAD)

Study Finds Ulcerated Plaque in the Femoropopliteal Artery as Source of Arterial Embolism in the Popliteal Arteries

February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School of ...

February 21, 2022

An ultrasound is taken of a patient's heart.

News | Cardiac Imaging

A Non-invasive Way to Predict Heart Attack and Stroke

February 21, 2022 – Acute coronary syndromes (such as heart attacks) and strokes are a leading cause of morbidity and ...

February 21, 2022

Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of its Aquadex therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening heart failure through its randomized controlled trial, Ultrafiltration Versus IV Diuretics in Worsening Heart Failure, the REVERSE-HF Study.

News | Heart Failure

Nuwellis Initiates REVERSE-HF Study to Evaluate Ultrafiltration for Heart Failure Patients with Fluid Overload

February 21, 2022 – Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of ...

February 21, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Pipeline for creating synthetic images and validation process.

News | Cardiac Imaging

New Tool for 3-D Measurement of the Aorta May Identify Fatal Heart Conditions Earlier

February 21, 2022 – Researchers at Michigan Medicine have found a novel method of measuring growth in the body’s largest ...

February 21, 2022

Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. The patented orthopedic device, made of a high-performance polymer from Evonik, closes and holds the sternum securely together after surgery.

News | Cardiovascular Surgery

Evonik invests in U.S. start-up offering medical device to improve patient recovery after open-chest surgery

January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has ...

February 18, 2022

News | Heart Failure

Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Heart Failure

February 18, 2022 – Daxor Corporation, the global leader in blood volume measurement technology, has announced new data ...

February 18, 2022